What is Par Drugs And Chemicals Ltd (PAR) share price return in the past 10 years?

Data is not available for this company

What is the share price of Par Drugs And Chemicals Ltd (PAR)?

Company share prices are keep on changing according to the market conditions. The current trading price of Par Drugs And Chemicals Ltd (PAR) on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Par Drugs And Chemicals?

The latest standalone P/E ratio of Par Drugs And Chemicals as of 01-Jan-1970 is 8.14.

What is the P/B ratio of Par Drugs And Chemicals Ltd (PAR)?

The latest standalone P/B ratio of Par Drugs And Chemicals Ltd (PAR) as of 01-Jan-1970 is 0.95.

What is the 52-week high and low of Par Drugs And Chemicals Ltd (PAR)?

The 52-week high of Par Drugs And Chemicals Ltd (PAR) is Rs. 0.00 and the 52-week low is Rs. 0.00.

Par Drugs And Chemicals Ltd (PAR) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Par Drugs And Chemicals Ltd (PAR)
Brand: Par Drugs And Chemicals

Par Drugs And Chemicals Ltd (PAR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: PAR Pharmaceuticals & Drugs | Small Cap | Par Drugs & Chem. Share Price

Par Drugs And Chemicals Ltd (PAR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: PAR Pharmaceuticals & Drugs | Small Cap | Par Drugs & Chem. Share Price

Key Metrics

Valuation Multiples

Market Cap

₹107 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹10.7

TTM Sales

₹104 Cr.

Book Value per Share

₹91

P/E Ratio

8.14

Lower than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

0.95

Lower than its 5-year historical median

Price to Sales (P/S)

1.03

Lower than its 5-year historical median

EV/EBITDA

3.07

Lower than its 5-year historical median

Dividend Yield

0.00%

Profitability Efficiency

Return on Equity (ROE)

14.47%

Outperforms industry median

Return on Capital Employed (ROCE)

19.51%

Outperforms industry median

Return on Assets (ROA)

12.09%

Operating Profit Margin

19.3%

Net Profit Margin

13.23%

Gross Profit Margin

19%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

5.57%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-14.55%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-7.86%

Asset Quality

Promoter Holding

73.41%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹100 Cr.

Equity

₹12.3 Cr.

Face Value

₹10

All Time Low / High

- / -

Par Drugs And Chemicals stock performance

Key Ratios

Check Before You Invest

Quality

Very Good

Check detailed performance

Valuation

Undervalued

Check Valuation charts

Price Trend

Semi Strong

Check Price chart

Q.1 Is Par Drugs And Chemicals Ltd a good quality company?

Par Drugs And Chemicals Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Par Drugs And Chemicals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Par Drugs And Chemicals Ltd vs industry peers?

Par Drugs And Chemicals Ltd revenue CAGR is 12.57%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Par Drugs And Chemicals Ltd?

Promoters hold 73.41% of the Par Drugs And Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Par Drugs And Chemicals Ltd over the last decade?

Over the last 5 year(s), the stock has delivered a CAGR of 4.77% based on the current price.

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	9.4%	12.3%	11.2%	12.4%	15.6%	28.7%	21.9%	23.2%	25%	19.5%	-
Value Creation Index ⓘ	-0.3	-0.1	-0.2	-0.1	0.1	1.1	0.6	0.7	0.8	0.4	-
Growth Parameters ⓘ
Sales ⓘ	33.3	48.8	42.4	46.3	55.9	60.8	75.1	95.8	95.6	101	104
Sales YoY Gr.	-	46.6%	-13.1%	9.3%	20.6%	8.8%	23.6%	27.6%	-0.1%	5.6%	-
Adj EPS ⓘ	0.8	3.4	2.8	2.8	3.9	8.3	7.5	9.1	11.8	10.3	10.7
YoY Gr.	-	337.2%	-17.3%	-0.4%	37%	115.8%	-9.9%	21.8%	29.2%	-13%	-
BVPS (₹) ⓘ	21.5	24.9	28.2	32.4	33	42.4	48.7	57.9	69.6	80.4	91
Adj Net Profit ⓘ	0.4	1.8	1.5	2.5	4.7	10.2	9.2	11.2	14.5	12.6	13
Cash Flow from Ops. ⓘ	6.5	9.2	4.7	3.4	7.7	12.1	7.6	13.4	20.3	16.2	-
Debt/CF from Ops. ⓘ	4.7	2.7	5	3.5	0.8	0.7	0	0	0	0	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	13.1%	12.6%	10.4%	5.6%
Adj EPS ⓘ	33.1%	21.6%	11%	-13%
BVPSⓘ	15.8%	19.5%	18.2%	15.6%
Share Price	-	5.5%	-25.8%	-13.7%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	2.5	10.1	7.6	10.1	13.6	22	16.4	17.1	18.5	13.7	12.4
Op. Profit Mgn % ⓘ	21.6	17.4	18.9	17.7	16.9	26.4	21.7	19	23.9	19.3	16.5
Net Profit Mgn % ⓘ	1.3	3.8	3.6	5.4	8.5	16.8	12.3	11.7	15.2	12.5	12.6
Debt to Equity ⓘ	1.8	1.3	1.1	0.4	0.2	0.2	0	0	0	0	0
Working Cap Days ⓘ	153	108	110	102	93	101	105	94	88	83	123
Cash Conv. Cycle ⓘ	51	33	29	42	38	30	32	34	35	30	93

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	33	49	42	46	56	61	75	96	96	101
Operating Expenses ⓘ +	26	40	34	38	46	45	59	78	73	81
Manufacturing Costs	8	12	10	12	14	14	18	23	22	26
Material Costs	13	21	18	19	24	22	29	40	34	38
Employee Cost	2	2	2	2	3	3	3	3	4	4
Other Costs ⓘ	3	5	5	5	6	7	9	11	13	14
Operating Profit ⓘ	7	8	8	8	9	16	16	18	23	20
Operating Profit Margin (%)	21.6%	17.4%	18.9%	17.7%	16.9%	26.4%	21.7%	19.0%	23.9%	19.3%
Other Income ⓘ +	0	0	0	0	0	0	0	0	0	2
Exceptional Items ⓘ	0	0	0	0	0	2	0	0	0	0
Interest ⓘ	4	3	2	2	1	1	0	0	0	0
Depreciation ⓘ	3	3	3	3	3	3	3	3	3	4
Profit Before Tax ⓘ	1	3	3	3	6	15	13	15	20	18
Tax ⓘ	1	1	1	1	1	3	3	4	5	5
Profit After Tax	0	2	2	3	5	12	9	11	15	13
PAT Margin (%)	1.3%	3.8%	3.6%	5.4%	8.5%	19.1%	12.3%	11.8%	15.2%	13.2%
Adjusted EPS (₹)	0.8	3.4	2.8	2.8	3.9	9.4	7.5	9.2	11.8	10.9
Dividend Payout Ratio (%)	0%	0%	0%	0%	32.30%	0%	16.70%	0%	0%	0%

Valuation of Par Drugs & Chem. - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	17	19	21	29	41	52	60	71	86	99
Share Capital ⓘ	8	8	8	4	6	6	12	12	12	12
Reserves ⓘ	9	11	13	25	34	46	48	59	73	87
Debt +	26	21	18	10	5	8	0	0	0	0
Long Term Debt	16	14	13	6	5	4	0	0	0	0
Short Term Debt	10	7	5	4	0	3	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	6	8	5	5	6	7	11	8	5	11
Others Liabilities ⓘ	8	8	10	7	9	10	8	10	11	10
Total Liabilities ⓘ	58	56	54	51	60	76	79	89	102	119
Fixed Assets
Net Fixed Assets ⓘ +	43	42	39	36	34	30	34	38	41	39
Gross Block	54	56	56	57	57	53	60	68	74	75
Accumulated Depreciation	12	14	17	20	23	23	26	29	33	36
CWIP ⓘ	0	0	0	0	1	5	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	25
Inventories	6	4	4	4	3	3	5	5	4	6
Trade Receivables	7	8	9	9	12	12	18	17	14	17
Cash Equivalents	1	0	0	0	7	21	16	22	37	28
Others Assets ⓘ	1	2	2	2	2	5	5	6	6	5
Total Assets ⓘ	58	56	54	51	60	76	79	89	102	119

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	7	9	5	3	8	12	8	13	20	16
PBT ⓘ	1	3	3	3	6	15	13	15	20	18
Adjustment ⓘ	6	5	5	4	3	1	3	3	3	3
Changes in Working Capital ⓘ	-1	1	-3	-4	-1	-0	-5	-0	2	0
Tax Paid ⓘ	-0	-1	-0	-1	-1	-4	-3	-4	-4	-5
Cash Flow From Investing Activity ⓘ +	-0	-2	-1	-0	-1	0	-3	-7	-6	-25
Capex	-0	-2	-1	-0	-2	-0	-3	-7	-6	-1
Net Investments	-0	0	0	0	0	0	0	0	-0	-25
Others ⓘ	0	0	0	0	0	0	0	0	0	1
Cash Flow From Financing Activity ⓘ +	-5	-8	-4	-3	1	2	-10	-0	0	0
Net Proceeds from Shares ⓘ	0	0	0	6	9	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	-5	-2	-1	-7	-1	-0	-4	0	0	0
Interest Paid ⓘ	-4	-2	-2	-2	-1	-1	-0	-0	0	0
Dividend Paid ⓘ	-0	-0	-0	-0	-1	-1	-2	0	0	0
Others ⓘ	3	-3	-1	-1	-4	3	-3	0	0	0
Net Cash Flow ⓘ	1	-1	0	-0	7	14	-5	6	14	-9

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	3.69	14.75	10.63	11.35	13.68	25.02	16.44	17.29	18.49	14.47
ROCE (%)	9.36	12.34	11.19	12.41	15.56	28.68	21.85	23.2	25.02	19.51
Asset Turnover Ratio	0.57	0.86	0.88	1.01	1.14	1.01	1.09	1.29	1.13	1.03
PAT to CFO Conversion(x)	N/A	4.5	2.5	1	1.6	1	0.89	1.18	1.33	1.23
Working Capital Days
Receivable Days	81.70	58	63.30	59.40	60	65.60	66.50	59.70	52.20	49
Inventory Days	52.40	35.80	30.30	28.80	20.70	15.60	16.60	17	16.30	16.60
Payable Days	184.50	123.20	132.80	96.80	85.90	107.80	110	84.90	72.60	77.80

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Par Drugs And Chemicals Ltd FAQs

The current trading price of Par Drugs & Chem. on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Par Drugs & Chem. stood at ₹106.7 Cr

The latest P/E ratio of Par Drugs & Chem. as of 31-Dec-1969 is 8.14.

The latest P/B ratio of Par Drugs & Chem. as of 31-Dec-1969 is 0.95.

The 52-week high of Par Drugs & Chem. is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Par Drugs & Chem. is ₹104 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Par Drugs And Chemicals Ltd is a good quality company.

The key valuation ratios of Par Drugs And Chemicals Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Par Drugs And Chemicals Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Par Drugs And Chemicals Ltd

No data to display

Par Drugs And Chemicals Ltd (PAR)

Par Drugs And Chemicals Ltd (PAR)

Par Drugs And Chemicals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Par Drugs & Chem. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Par Drugs And Chemicals Ltd FAQs

About Par Drugs And Chemicals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Par Drugs And Chemicals Ltd (PAR)

Par Drugs And Chemicals Ltd (PAR)

Par Drugs And Chemicals stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Par Drugs & Chem. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Par Drugs And Chemicals Ltd FAQs

What is the share price of Par Drugs & Chem.?

What is the market cap of Par Drugs & Chem.?

What is the P/E ratio of Par Drugs & Chem.?

What is the P/B ratio of Par Drugs & Chem.?

What is the 52-week high and low of Par Drugs & Chem.?

What is the TTM revenue of Par Drugs & Chem.?

Is Par Drugs And Chemicals Ltd a good quality company?

Is Par Drugs And Chemicals Ltd undervalued or overvalued?

Is Par Drugs And Chemicals Ltd a good buy now?

About Par Drugs And Chemicals Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.